BeOne Medicines AG

NasdaqGS:ONC Stock Report

Market Cap: US$35.4b

BeOne Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ONC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Sep 25BuyUS$3,034,068Capital Research and Management CompanyCompany67,875.63US$44.70
02 Sep 25SellUS$39,865Titus BallIndividual122US$326.76
11 Aug 25SellUS$15,891,389Capital Research and Management CompanyCompany55,078.47US$288.52
01 Aug 25SellUS$345,659Aaron RosenbergIndividual1,190US$290.47
30 Jul 25SellUS$280,233Chan LeeIndividual920US$304.60
23 Jun 25SellUS$830,360John OylerIndividual3,174US$262.90
23 Jun 25SellUS$354,380Xiaobin WuIndividual1,363US$260.00
23 Jun 25SellUS$267,280Wang LaiIndividual1,028US$260.00
17 Jun 25SellUS$374,473John OylerIndividual1,460US$256.49
17 Jun 25SellUS$567,742Xiaobin WuIndividual2,173US$266.22
17 Jun 25SellUS$118,142Wang LaiIndividual470US$251.37
16 Jun 25SellUS$112,463Chan LeeIndividual422US$266.50
16 Jun 25SellUS$979,046John OylerIndividual3,680US$266.05
16 Jun 25SellUS$313,558Wang LaiIndividual1,177US$266.40
11 Jun 25SellUS$34,620Titus BallIndividual134US$258.36
06 Jun 25SellUS$1,295,946John OylerIndividual5,127US$255.74
06 Jun 25SellUS$489,591Xiaobin WuIndividual1,934US$255.77
06 Jun 25SellUS$353,853Wang LaiIndividual1,402US$255.30
06 Jun 25SellUS$179,280Chan LeeIndividual700US$256.79
25 Mar 25SellUS$11,527,575Capital Research and Management CompanyCompany45,777.26US$251.82
04 Mar 25SellUS$2,073,826Xiaodong WangIndividual8,146US$257.41
28 Feb 25SellUS$190,535,020Baker Bros. Advisors LPCompany732,827US$260.00
21 Feb 25SellUS$1,286,174Wang LaiIndividual5,000US$260.17
09 Dec 24SellUS$7,700,043Baker Bros. Advisors LPCompany37,017US$208.01
09 Dec 24SellUS$186,500,000Baker Bros. Advisors LPCompany1,000,000US$186.50
02 Dec 24SellUS$3,568,500,000HHLR Advisors, Ltd.Company17,842,500US$200.00

Insider Trading Volume

Insider Buying: ONC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONC?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme138,2400.126%
Private Companies368,3850.335%
Individual Insiders5,066,0714.6%
Hedge Funds8,799,0537.99%
Public Companies18,938,11917.2%
General Public28,688,65826.1%
Institutions48,060,09943.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.2%
Amgen Inc.
18,938,119US$6.1b0%no data
7.99%
Baker Bros. Advisors LP
8,799,053US$2.8b0%17.75%
5.41%
Capital Research and Management Company
5,950,466US$1.9b6.38%0.08%
4.62%
PRIMECAP Management Company
5,088,279US$1.6b0.65%1.12%
4.11%
HHLR Advisors, Ltd.
4,527,507US$1.5b-25.8%14.88%
3.67%
John Oyler
4,036,550US$1.3b-1.36%no data
3.11%
FMR LLC
3,427,536US$1.1b-0.1%0.06%
2.84%
BlackRock, Inc.
3,130,127US$1.0b5.93%0.01%
2.38%
The Vanguard Group, Inc.
2,618,387US$842.4m-7.97%0.01%
1.58%
T. Rowe Price Group, Inc.
1,741,516US$560.3m-1.1%0.05%
1.35%
Norges Bank Investment Management
1,485,346US$477.9m36.2%0.03%
1.05%
Bosera Asset Management Co., Ltd.
1,150,472US$370.1m0%1.25%
0.94%
Hillhouse Investment Management, Ltd.
1,034,485US$332.8m0%2.95%
0.92%
Temasek Holdings (Private) Limited
1,010,465US$325.1m1.68%0.22%
0.68%
Xiaodong Wang
749,041US$241.0m1.8%no data
0.65%
GF Fund Management Co., Ltd.
717,621US$230.9m0%0.39%
0.49%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
542,097US$174.4m4.55%0.03%
0.49%
Citadel Advisors LLC
537,156US$172.8m-45.3%0.15%
0.46%
Artal Group S.A.
509,990US$164.1m2.27%4.1%
0.43%
China Asset Management Co. Ltd.
475,251US$152.9m8.9%0.14%
0.42%
Marshall Wace LLP
467,590US$150.4m-2%0.2%
0.36%
ICBC Credit Suisse Fund Management Co., Ltd
398,099US$128.1m0%0.71%
0.34%
UBS Asset Management AG
372,177US$119.7m45.7%no data
0.33%
Guangzhou Development District Holding Group Limited
368,385US$118.5m0%no data
0.33%
SDIC Chuangyi Industry Fund Management Co., Ltd.
368,385US$118.5m0%9.77%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/09 23:28
End of Day Share Price 2025/11/07 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BeOne Medicines AG is covered by 65 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tianli WenAletheia Analyst Network Limited
Brian SkorneyBaird
Peter LawsonBarclays